Rheumatoid arthritis has an insidious onset
Conditions
Interventions
Single large-dose intramuscular steroid group:None
Short-term low-dose oral steroid group:None
Sponsors
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with RA in the included studies met the 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for rheumatoid arthritis and were active (DAS28>2.6). From January 2020 to August 2024, he received a single high-dose corticosteroid injection (1ml of compound betamethasone injection) or a short-term low-dose hormone therapy in the outpatient department of rheumatology and immunology of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. The information such as gender, age, start and end time of treatment, and drug dosage were complete, and regular follow-up and follow-up data were complete.
Exclusion criteria
Exclusion criteria: Patients with RA with unclear diagnosis, absence of key information, incomplete follow-up data, and with factors that may interfere with the results of the study, e.g., patients with serious comorbidities, pregnant patients are excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease Remission Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease Activity Score;Imaging Evaluation Indicators;Health Assessment Questionnaire;Liver and kidney function, Blood pressure, blood glucose, blood lipids, Body Mass Index;Bone Mineral Density (BMD); | — |
Countries
China
Contacts
Public ContactLiu Honglei
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed